BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9921917)

  • 1. Cytogenetic study of acute myeloid leukemia: comparison of data obtained in 1991-1996 and 1982-1988.
    Musilová J; Michalová K; Zemanová Z; Brezinová Z; Dohnalová A; Sajdová J
    Neoplasma; 1998; 45(5):292-5. PubMed ID: 9921917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
    Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
    Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
    Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
    Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia.
    Brozek I; Babińska M; Kardaś I; Woźniak A; Balcerska A; Hellmann A; Limon J
    J Appl Genet; 2003; 44(3):401-12. PubMed ID: 12923315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements.
    Lindvall C; Nordenskjöld M; Porwit A; Björkholm M; Blennow E
    Haematologica; 2001 Nov; 86(11):1158-64. PubMed ID: 11694401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation (3;12)(q25;p11.2): a recurrent cytogenetic abnormality in acute myeloid leukemia.
    Shah R; Rowland B; Richkind K; Mowery-Rushton P; Roherty S; Morgan R; Schlam M
    Cancer Genet Cytogenet; 2005 Jan; 156(2):186-7. PubMed ID: 15642404
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
    Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
    Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.
    Fröhling S; Skelin S; Liebisch C; Scholl C; Schlenk RF; Döhner H; Döhner K;
    J Clin Oncol; 2002 May; 20(10):2480-5. PubMed ID: 12011125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
    Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
    Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900).
    Vance GH; Kim H; Hicks GA; Cherry AM; Higgins R; Hulshizer RL; Tallman MS; Fernandez HF; Dewald GW
    Leuk Res; 2007 May; 31(5):605-9. PubMed ID: 16996130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests.
    Díez-Martín JL; Buño I; Llamas P; Gosálvez J; López-Fernández C; Polo N; Regidor C
    Cancer Detect Prev; 2000; 24(2):169-72. PubMed ID: 10917138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.
    Lindvall C; Furge K; Björkholm M; Guo X; Haab B; Blennow E; Nordenskjöld M; Teh BT
    Haematologica; 2004 Sep; 89(9):1072-81. PubMed ID: 15377468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic and clinical study of myeloid leukemia].
    Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.